2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Ethical Considerations in Genetic Engineering and Therapy

The rapid progress in gene therapy gives rise to critical ethical concerns about informed consent, safety, and accessibility. The ethical implications of modifying human DNA will be discussed, focusing on bodily versus germline editing. The challenges include navigating regulatory environments, resolving public concerns about genetic changes, and maintaining fair access to medicines. Including stakeholders in discussions—such as ethicists, healthcare providers, and patients—can aid in the creation of complete suggestions that strike a balance between innovation and moral obligation at Cell & Gene Therapy World Conference 2026

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis